JP2023553094A5 - - Google Patents
Info
- Publication number
- JP2023553094A5 JP2023553094A5 JP2023534880A JP2023534880A JP2023553094A5 JP 2023553094 A5 JP2023553094 A5 JP 2023553094A5 JP 2023534880 A JP2023534880 A JP 2023534880A JP 2023534880 A JP2023534880 A JP 2023534880A JP 2023553094 A5 JP2023553094 A5 JP 2023553094A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- substituted
- atoms
- alkyl
- hydrogen atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063122181P | 2020-12-07 | 2020-12-07 | |
| US63/122,181 | 2020-12-07 | ||
| PCT/CA2021/051755 WO2022120475A1 (en) | 2020-12-07 | 2021-12-07 | 3-cyclic amine-indole derivatives as serotonergic agents for the treatment of cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553094A JP2023553094A (ja) | 2023-12-20 |
| JP2023553094A5 true JP2023553094A5 (https=) | 2024-12-06 |
Family
ID=81973031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534880A Pending JP2023553094A (ja) | 2020-12-07 | 2021-12-07 | 中枢神経系障害の治療のためのセロトニン作動性薬としての３位環－アミンインドール誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240051978A1 (https=) |
| EP (1) | EP4255913A4 (https=) |
| JP (1) | JP2023553094A (https=) |
| KR (1) | KR20230117597A (https=) |
| CN (1) | CN116917305A (https=) |
| AU (1) | AU2021394129A1 (https=) |
| CA (1) | CA3201080A1 (https=) |
| IL (1) | IL303467A (https=) |
| MX (1) | MX2023006652A (https=) |
| WO (1) | WO2022120475A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519816A4 (en) | 2016-09-29 | 2020-05-06 | The Regents of the University of California | CONNECTIONS FOR INCREASING NEURONAL PLASTICITY |
| KR102946120B1 (ko) | 2019-02-27 | 2026-03-30 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클 |
| US20240286998A1 (en) * | 2021-06-02 | 2024-08-29 | Saint Joseph's University | Fluorinated tryptamine compounds, analogues thereof, and methods using same |
| IL313455A (en) | 2021-12-15 | 2024-08-01 | Delix Therapeutics Inc | Phenoxy and benzyloxy modified psychroplastogens and their uses |
| WO2023114472A1 (en) * | 2021-12-16 | 2023-06-22 | Icahn School Of Medicine At Mount Sinai | Heterocyclic compounds as 5ht2a biased agonists |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| US20250325516A1 (en) * | 2022-07-08 | 2025-10-23 | Institut Curie | Serotonin analogues for use in treating metalloptosis-associated disorders |
| US12396981B2 (en) | 2023-03-09 | 2025-08-26 | William Shulman | Methods of using DMT |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5789402A (en) * | 1995-01-17 | 1998-08-04 | Eli Lilly Company | Compounds having effects on serotonin-related systems |
| US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| US6133287A (en) * | 1998-03-24 | 2000-10-17 | Allelix Biopharmaceuticals Inc. | Piperidine-indole compounds having 5-HT6 affinity |
| GB9810886D0 (en) * | 1998-05-13 | 1998-07-22 | Lilly Industries Ltd | Pharmaceutical compounds |
| ATE375990T1 (de) * | 1999-04-21 | 2007-11-15 | Nps Allelix Corp | Piperidin-indol derivate mit 5-ht6 affinität |
| WO2004069828A1 (ja) * | 2003-02-04 | 2004-08-19 | Mitsubishi Pharma Corporation | ピペリジン化合物およびその医薬用途 |
| WO2005066157A1 (en) * | 2004-01-02 | 2005-07-21 | Suven Life Sciences | 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
| EP1984351A1 (en) * | 2006-02-17 | 2008-10-29 | Memory Pharmaceuticals Corporation | Compounds having 5-ht6 receptor affinity |
| EP2464227A4 (en) * | 2009-08-10 | 2013-02-20 | Galenea Corp | COMPOUNDS AND METHODS OF USE |
| AU2021373520A1 (en) * | 2020-11-06 | 2023-06-29 | Mynd Life Sciences Inc. | A method of treating depression by immune modulation |
-
2021
- 2021-12-07 JP JP2023534880A patent/JP2023553094A/ja active Pending
- 2021-12-07 CN CN202180092982.XA patent/CN116917305A/zh active Pending
- 2021-12-07 US US18/265,286 patent/US20240051978A1/en active Pending
- 2021-12-07 WO PCT/CA2021/051755 patent/WO2022120475A1/en not_active Ceased
- 2021-12-07 CA CA3201080A patent/CA3201080A1/en active Pending
- 2021-12-07 KR KR1020237023111A patent/KR20230117597A/ko active Pending
- 2021-12-07 EP EP21901751.4A patent/EP4255913A4/en active Pending
- 2021-12-07 IL IL303467A patent/IL303467A/en unknown
- 2021-12-07 AU AU2021394129A patent/AU2021394129A1/en active Pending
- 2021-12-07 MX MX2023006652A patent/MX2023006652A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023553094A5 (https=) | ||
| JP2023513679A5 (https=) | ||
| JP2023512821A5 (https=) | ||
| IL295371A (en) | Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders | |
| JP5791612B2 (ja) | ピリド［３，４−ｂ］インドールおよび使用方法 | |
| JP5586577B2 (ja) | 架橋複素環化合物およびその使用 | |
| CN102480956B (zh) | 吡啶并[4,3-b]吲哚类和使用方法 | |
| JP5779183B2 (ja) | ピリド［４，３−ｂ］インドールおよび使用方法 | |
| JP5869484B2 (ja) | 架橋複素環化合物およびその使用 | |
| JP6933964B2 (ja) | ヘテロアリール化合物およびそれらの使用方法 | |
| JP2024508922A5 (https=) | ||
| JP6421185B2 (ja) | ベンゾイミダゾール−プロリン誘導体の使用 | |
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| JP2024508545A5 (https=) | ||
| JP2023553094A (ja) | 中枢神経系障害の治療のためのセロトニン作動性薬としての３位環－アミンインドール誘導体 | |
| JP2019534327A5 (https=) | ||
| CA3172692C (en) | 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof | |
| CA3210275A1 (en) | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto | |
| JP2025513462A5 (https=) | ||
| IL316416A (en) | Indoline derivatives as estrogenic agents for the treatment of disorders | |
| JP2025513461A5 (https=) | ||
| JP2017502069A (ja) | 有機化合物 | |
| CA2450274A1 (en) | Benzoxazepine derivatives and their use as ampa receptor stimulators | |
| JP2019535715A5 (https=) | ||
| FI3541784T3 (fi) | Uudet atsetidiinijohdannaiset, jotka ovat hyödyllisiä kortikaalisen katekoliamiini-neurotransmission modulaattoreina |